These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23985419)

  • 1. Can we teach old dogs new tricks? Neuroprotective cell therapy in Alzheimer's and Parkinson's disease.
    Kazmerova Z; Zilka N; Cente M; Neradil P; Zilkova M; Novak M
    J Alzheimers Dis; 2013; 37(2):251-72. PubMed ID: 23985419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.
    Korecka JA; Verhaagen J; Hol EM
    Regen Med; 2007 Jul; 2(4):425-46. PubMed ID: 17635050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases.
    Radad K; Moldzio R; Al-Shraim M; Kranner B; Krewenka C; Rausch WD
    CNS Neurol Disord Drug Targets; 2017; 16(7):740-748. PubMed ID: 28641510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADSC therapy in neurodegenerative disorders.
    Chan TM; Chen JY; Ho LI; Lin HP; Hsueh KW; Liu DD; Chen YH; Hsieh AC; Tsai NM; Hueng DY; Tsai ST; Chou PW; Lin SZ; Harn HJ
    Cell Transplant; 2014; 23(4-5):549-57. PubMed ID: 24816450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.
    Shetty AK; Bates A
    Brain Res; 2016 May; 1638(Pt A):74-87. PubMed ID: 26423935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adult neurogenesis and stem cells. Functional capacity].
    Reinoso Suárez F
    An R Acad Nac Med (Madr); 2002; 119(3):507-21; discussion 521-8. PubMed ID: 12812039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of transcription factors in cell replacement therapies for neurodegenerative conditions.
    Thomas M
    Regen Med; 2010 May; 5(3):441-50. PubMed ID: 20455654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural stem cell therapy in the aging brain: pitfalls and possibilities.
    Limke TL; Rao MS
    J Hematother Stem Cell Res; 2003 Dec; 12(6):615-23. PubMed ID: 14977471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of gene therapy in major brain diseases].
    Fan L; Jiang XG
    Yao Xue Xue Bao; 2010 Sep; 45(9):1095-102. PubMed ID: 21351564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Olfactory disorders in Alzheimer's disease and in Parkinson's disease. Review of the literature].
    Norès JM; Biacabe B; Bonfils P
    Ann Med Interne (Paris); 2000 Mar; 151(2):97-106. PubMed ID: 10855362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Restoration of brain function by cell transplantation].
    Kakishita K; Nakao N; Itakura T
    Nihon Rinsho; 2003 Mar; 61(3):457-62. PubMed ID: 12701173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
    Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
    Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Theoretic basis on the same therapeutic program for different degenerative brain diseases in terms of the Governor Vessel: Alzheimer's disease and Parkinson's disease].
    Wu J; Wang J; Zhang J
    Zhongguo Zhen Jiu; 2015 May; 35(5):489-92. PubMed ID: 26255528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.
    Van Bulck M; Sierra-Magro A; Alarcon-Gil J; Perez-Castillo A; Morales-Garcia JA
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30743990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuronal death and growth factors: new therapeutic approaches in Parkinson's disease].
    Wider C; Burkhard PR; Sajadi A; Vingerhoets FJ
    Rev Med Suisse; 2006 May; 2(64):1158-62. PubMed ID: 16734187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent stem cells as new drugs? The example of Parkinson's disease.
    Preynat-Seauve O; Burkhard PR; Villard J; Zingg W; Ginovart N; Feki A; Dubois-Dauphin M; Hurst SA; Mauron A; Jaconi M; Krause KH
    Int J Pharm; 2009 Nov; 381(2):113-21. PubMed ID: 19782880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.
    Nobre RJ; Almeida LP
    Curr Pharm Des; 2011; 17(31):3434-45. PubMed ID: 21902665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of neurodegenerative disorders: Parkinson's disease and Alzheimer's disease.
    Pal PK; Netravathi M
    J Indian Med Assoc; 2005 Mar; 103(3):168-70, 172, 174-6. PubMed ID: 16173294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.